Peter A Calabresi, Gavin Giovannoni, Hans-Peter Hartung, Robert T Naismith, Robert J Fox, Maria Pia Sormani, Douglas L Arnold, Ludwig Kappos, Martin Valis, Scott D Newsome, Martin I Belkin, Emmanuel Bartholomé, Katherine Riester, Andrija Javor, Jennifer Lyons, Daniel P Bradley, Elizabeth Fisher, Ian Tagge, Maria L Naylor, Shibeshih Belachew, Aaron Deykin, Nathalie Franchimont, Bing Zhu, Wenting Cheng.
Oxidized MIF is an Alzheimer's disease drug target relaying external risk factors to tau pathology.Safety and efficacy of opicinumab in participants with relapsing multiple sclerosis (AFFINITY Part 1): A randomized, controlled, phase 2 trial.
Mult Scler. 2026 Jan;32(1):107-120. doi: 10.1177/13524585251396433. Epub 2025 Dec 26. PubMed ID: 41454463
Further Information:
DOI: 10.1177/13524585251396433
Hans-Peter Hartung